21 Dejung B. Triggerpunkt-Therapie: Die Behandlungakuter Und chronischer Schmerzenim Bewegungsapparatmitmanueller Triggerpunkt-Therapie und Dry Needling. Berno, Hans Huber 2009; 13-37
Aird L, Samuel D, Stokes M Quadriceps muscle tone, elasticity and stiffness in older males: reliability and symmetry using the MyotonPRO. Arch Gerontol Geriatr. 2012 Sep-Oct;55(2):e31-9. doi: 10.1016/j.archger.2012.03.005. Epub 2012 Apr 13.
Bengtsson A, Henriksson KG, Larsson J Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum. 1986 Jul;29(7):817-21. doi: 10.1002/art.1780290701.
Bizzini M, Mannion AF Reliability of a new, hand-held device for assessing skeletal muscle stiffness. Clin Biomech (Bristol, Avon). 2003 Jun;18(5):459-61. doi: 10.1016/s0268-0033(03)00042-1.
Boska MD, Welch KM, Barker PB, Nelson JA, Schultz L Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002 Apr 23;58(8):1227-33. doi: 10.1212/wnl.58.8.1227.
Bron C, Franssen J, Wensing M, Oostendorp RA Interrater reliability of palpation of myofascial trigger points in three shoulder muscles. J Man Manip Ther. 2007;15(4):203-15. doi: 10.1179/106698107790819477.
Calandre EP, Hidalgo J, Garcia-Leiva JM, Rico-Villademoros F Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition? Eur J Neurol. 2006 Mar;13(3):244-9. doi: 10.1111/j.1468-1331.2006.01181.x.
Chaitow L, Fritz L A Massage Therapist's Guide to Understanding, Locating and Treating Myofascial Trigger Points. Churchill Livingstone, Edinburgh 2006
Chen Q, Basford J, An KN Ability of magnetic resonance elastography to assess taut bands. Clin Biomech (Bristol, Avon). 2008 Jun;23(5):623-9. doi: 10.1016/j.clinbiomech.2007.12.002. Epub 2008 Feb 21. Erratum In: Clin Biomech (Bristol, Avon). 2009 Mar;24(3):314.
Crooks DI, Newington K, Pilling L, Todd M Assessing the feasibility of mobilisation of C0-C3 cervical segments to reduce headache in migraineurs. Int J Ther Reh 2018; 25(8): 382-394
Dahlof C, Linde M One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia. 2001 Jul;21(6):664-71. doi: 10.1046/j.1468-2982.2001.00218.x.
Dahlof CG, Dimenas E Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia. 1995 Feb;15(1):31-6. doi: 10.1046/j.1468-2982.1995.1501031.x.
Diener HC, Holle D, Dodick D Treatment of chronic migraine. Curr Pain Headache Rep. 2011 Feb;15(1):64-9. doi: 10.1007/s11916-010-0159-x.
Edvinsson L Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications. CNS Drugs. 2001;15(10):745-53. doi: 10.2165/00023210-200115100-00001.
Fernandez-de-Las-Penas C, Simons D, Cuadrado ML, Pareja J The role of myofascial trigger points in musculoskeletal pain syndromes of the head and neck. Curr Pain Headache Rep. 2007 Oct;11(5):365-72. doi: 10.1007/s11916-007-0219-z.
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001 Nov 17;358(9294):1668-75. doi: 10.1016/S0140-6736(01)06711-3.
Ge HY, Fernandez-de-Las-Penas C, Yue SW Myofascial trigger points: spontaneous electrical activity and its consequences for pain induction and propagation. Chin Med. 2011 Mar 25;6:13. doi: 10.1186/1749-8546-6-13.
Gerwin RD, Dommerholt J, Shah JP An expansion of Simons' integrated hypothesis of trigger point formation. Curr Pain Headache Rep. 2004 Dec;8(6):468-75. doi: 10.1007/s11916-004-0069-x.
Gozalov A, Jansen-Olesen I, Klaerke D, Olesen J Role of BK(Ca) channels in cephalic vasodilation induced by CGRP, NO and transcranial electrical stimulation in the rat. Cephalalgia. 2007 Oct;27(10):1120-7. doi: 10.1111/j.1468-2982.2007.01409.x. Epub 2007 Aug 21.
Horwitz S, Stewart A An Exploratory Study to Determine the Relationship between Cervical Dysfunction and Perimenstrual Migraines. Physiother Can. 2015 Winter;67(1):30-8. doi: 10.3138/ptc.2012-47.
Katsarava Z, Buse DC, Manack AN, Lipton RB Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012 Feb;16(1):86-92. doi: 10.1007/s11916-011-0233-z.
Koppen H, van Veldhoven PL Migraineurs with exercise-triggered attacks have a distinct migraine. J Headache Pain. 2013 Dec 21;14(1):99. doi: 10.1186/1129-2377-14-99.
Linde M Migraine: a review and future directions for treatment. Acta Neurol Scand. 2006 Aug;114(2):71-83. doi: 10.1111/j.1600-0404.2006.00670.x.
Linton-Dahlof P, Linde M, Dahlof C Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia. 2000 Sep;20(7):658-62. doi: 10.1111/j.1468-2982.2000.00099.x.
Simons D, Travell J Myofascial Pain and Dysfunction The Trigger Point Manual - Vol. 1 - Upper Half of Body 1998
Song TJ, Cho SJ, Kim WJ, Yang KI, Yun CH, Chu MK Sex Differences in Prevalence, Symptoms, Impact, and Psychiatric Comorbidities in Migraine and Probable Migraine: A Population-Based Study. Headache. 2019 Feb;59(2):215-223. doi: 10.1111/head.13470. Epub 2019 Jan 9.
Starling AJ, Vargas BB A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine. Curr Pain Headache Rep. 2015 Oct;19(10):49. doi: 10.1007/s11916-015-0521-0.
Stepien A Treatment of primary headaches. Pain 2011; 12 (4): 7-10
Tali D, Menahem I, Vered E, Kalichman L Upper cervical mobility, posture and myofascial trigger points in subjects with episodic migraine: Case-control study. J Bodyw Mov Ther. 2014 Oct;18(4):569-75. doi: 10.1016/j.jbmt.2014.01.006. Epub 2014 Feb 6.
Wells RE, Beuthin J, Granetzke L Complementary and Integrative Medicine for Episodic Migraine: an Update of Evidence from the Last 3 Years. Curr Pain Headache Rep. 2019 Feb 21;23(2):10. doi: 10.1007/s11916-019-0750-8.
Zhang LM, Dong Z, Yu SY Migraine in the era of precision medicine. Ann Transl Med. 2016 Mar;4(6):105. doi: 10.21037/atm.2016.03.13.
Effects of Myofascial Trigger Points Therapy in Migraine.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.